Why did lost sales cost Medifast almost as much in operating profit?

Medifast, a US company that sells weight-loss and nutrition products, booked revenue of USD 72.0m in Q3 2026, down 19.4% from USD 89.4m in Q3 2025. The operating loss widened to USD 19.4m from USD 4.1m, so the operating margin fell to -26.9%. The net loss reached USD 17.5m, against USD 2.3m a year before. Sales fell by USD 17.4m, but the operating result worsened by USD 15.3m. So almost every lost dollar of revenue reached the operating result.

A business with large fixed costs behaves this way. Staff, marketing and infrastructure do not shrink when sales do, so each lost dollar of revenue hits profit almost in full. The balance sheet can absorb it for now: the equity ratio is 75.2%, down from 80.1%, and cash stands at USD 58.4m, which is 41.4% less than a year ago. I would watch the cash line, because it fell faster than sales. The accounts do not show whether costs are being cut to match the lower revenue.